Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
نویسندگان
چکیده
منابع مشابه
Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignancies globally. Each year, more than 500,000 people worldwide are diagnosed with HCC. The onset of HCC is typically unnoticeable, and the prognosis is usually poor. The early diagnosis of HCC and dynamic monitoring of this disease can contribute to more effective therapeutic interventions and improve patient outcomes. To achieve ea...
متن کاملBiomarkers for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis prediction. Furthermore, it might represent certain therapeutic interventions through some combinations of biomarkers. Here, we review on our current understanding of HCC biomarkers.
متن کاملBiomarkers for Hepatocellular Carcinoma
The hepatocellular carcinoma (HCC) is one of the most common malignant tumors and carries a poor survival rate. The management of patients at risk for developing HCC remains challenging. Increased understanding of cancer biology and technological advances have enabled identification of a multitude of pathological, genetic, and molecular events that drive hepatocarcinogenesis leading to discover...
متن کاملCancer-Associated Carbohydrate Antigens as Potential Biomarkers for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common human malignancies. Therefore, developing the early, high-sensitivity diagnostic biomarkers to prevent HCC is urgently needed. Serum a-fetoprotein (AFP), the clinical biomarker in current use, is elevated in only ~60% of patients with HCC; therefore, identification of additional biomarkers is expected to have a significant impact on publi...
متن کاملNew Biomarkers for Hepatocellular Carcinoma
• Recent advances in genomic, proteomic and metabolomic technologies are enabling the identification of novel biomarkers for hepatocellular carcinoma (HCC). Most of these new markers are currently in phase 1 of biomarker development. • HCC biomarkers are mainly used as screening tools in surveillance programs for early HCC detection, with the ultimate goal of reduction in HCC mortality. Current...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Hepatocellular Carcinoma
سال: 2014
ISSN: 2253-5969
DOI: 10.2147/jhc.s44463